FibroGen (FGEN) Tops Q2 EPS by 14c

FibroGen (NASDAQ: FGEN) reported Q2 EPS of ($0.78), $0.14 better than the analyst estimate of ($0.92). Revenue for the quarter came in at $29.8 million versus the consensus estimate of $36.16 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• Key things to know ahead of SK Hynix’s blockbuster US listing
• Northern Technologies (NTIC) Misses Q3 EPS by 12c
• Donerail urges Beazer Homes board to engage with DFH's $32 offer